Natural Products Expo Asia 2005 Hong Kong Astaxanthin: A Radical Approach to Vitality & Beauty From Within Natural Products Expo Asia 2005 Vincent Wood PhD, Manager International Business Dept/Marketing NOV2004 Natural Products Expo Asia 2005 Hong Kong TO DAY’S PR E S E NTATI O N OUTLINE • What is Astaxanthin? • Why is it so potent compared to other carotenoid antioxidants? • The Research & Impact on Health • Summary of Recent Advances – Supplement use in Muscle Endurance, Eye health and Cosmetic benefit • Retail Examples in Japan • Regulatory, Production Technology & Supply NOV2004 Natural Products Expo Asia 2005 Hong Kong A MEMBER OF THE CAROTENOID FAMILY – Lutein – Astaxanthin -Carotene OH OH • 600 known carotenoids* • Humans cannot synthesise carotenoids. • Need to obtain carotenoids from food. • <25 obtained from food. • Basic carotene structure • Xanthophyll Class Lutein O OH HO O Astaxanthin Molecular Formula: Molecular Weight: CAS No: C40H52O4 596.82 472-61-7 *Parker RS.,1997 NOV2004 Natural Products Expo Asia 2005 Hong Kong ASTAXANTH I N BAC K G R O U N D 1938 Lobster Present Day Other Sources Microalgae Yeast Bacteria Higher Plants Crustaceans Fish Birds (Astacus gammarus) Discovered by Nobel Laureate Dr Kuhn (Haematococcus pluvialis) (Phaffia rhodozyma) (Agrobacterium aurantiacum) (Adonis aestivalis) (Euphasia supurba) (Salmon) Typically 1mg per 200g (Flamingo, Cockerel) NOV2004 Natural Products Expo Asia 2005 Hong Kong Haematococcus pluvialis Haemato (Blood) coccus (Seed) Microalgae family – includes Spirulina Harsh Environment – Dormant / Hibernates Astaxanthin “Astaxanthin efficiently functions as an antioxidant agent in both cytoplasmic and membraneous regions to protect cells in Powerful Antioxidant vivo against environmental oxidative Defence Against Free Radicals stress.” Protects Plant Cell Contents (1999 Kobayashi, M., Okada, T. Protective Role of Astaxanthin to Protect Against UVB Radiation in the Green Alga Haematococcus pluvialis.) Microalgae 15,000 ppm Yeast 8,000 ppm Krill 1,500 ppm. NOV2004 Natural Products Expo Asia 2005 Hong Kong ASTAXANTH I N M EAN S M O R E HENS FOR THE ROOSTER! COME HERE GIRLS! NOV2004 Natural Products Expo Asia 2005 Hong Kong ASTAXANTH I N & CAR OTE N O I D PERCEPTIONS Low level of consumer and retail awareness Contradictory carotenoid evidence. Not enough science -carotene>lycopene>lutein>astaxanthin Natural vs Synthetic Microalgae vs Yeast Perceived to be expensive! Unstable supply in the past, Intense competition Too many antioxidants on the market A functional based product is being developed based on microalgal astaxanthin only small amounts are required. Can complements existing formulations ‘Wait and see” attitude on market developments “Frost & Sullivan estimates that astaxanthin is now one of the fastest growing carotenoids in Europe. European carotenoids were worth $348.5 million in 2003, with 17 per cent of this coming from supplements. But currently less than 1 ton of astaxanthin is going into supplements per year, compared to up to 150 tons for the aquaculture industry.” Source: Nutraingredients.com 22/03/04 NOV2004 Natural Products Expo Asia 2005 Hong Kong ANTIOXIDANT MECHANISMS Physical Quenching 1O 2 + 1Carotenoid → 3O2 + 3Carotenoid* 3Carotenoid* → 1Carotenoid + thermal energy* ↓ ASTAXANTHIN ELIMINATES FREE RADICALS EXTREMELY FAST BY ENERGY TRANSFER** Chemical Reaction (e.g. -Carotene) 1O 2 + Carotenoid → Carotenoid RADICAL → OXIDIZED *B.R.Nielsen, K.Jorgensen and L.H.Skibsted : Triplet-triplet extinction coefficients, rate constants of triplet decay and rate constants of anthracene triplet sensitization by laser flash photolysis of astaxanthin, β-carotene, canthaxanthin and zeaxanthin in deaerated toluene at 298K, J.Photochem.Photobio.A:Chem., 112, 127-133 (1998). “The energy of the singlet state oxygen is quickly transferred to the carotenoid by direct contact, and the carotenoid in the triplet state relaxes to the singlet state very quickly by the transformation of the potential energy into thermal energy through the vibration of conjugated double bonds in the polyene chain.” (Miki, M., Biological Functions and Activities of Animal Carotenoids. Pure Appl. Chem. 63. 141-146. 1991.) NOV2004 Natural Products Expo Asia 2005 Hong Kong SCAVENGING EFFECT OF DIFFERENT ANTIOXIDANTS IN A LIPOPHILLIC IN VITRO MODEL 3500 ED 50 value (nM) 3000 2500 2000 1500 1000 500 0 Astaxanthin Zeaxanthin Cantaxanthin Lutein ß-Carotene Vitamin E Antioxidant Scavenging: Carotenoids with oxygen groups most efficient against lipid peroxidation. Astaxanthin was the most efficient scavenger. Miki, W. Pure & Appl. Chem. 63(1);141-46 NOV2004 Natural Products Expo Asia 2005 Hong Kong N E U T RA L I Z I N G R O S SOD 3O 2 e- → e- → H2O2 → (Hydroxy radicals) ・OH (Singlet oxygen radical) O2 ↓ LH → ↓ L・ → ↓ Astaxanthin LH H2O ↓ LOO・ → LOOH ↓ L・ QUENCHING 550 x Vitamin E* 40 x -carotene* (Peroxide radicals) Astaxanthin (Superoxide radical) ↓ 1O 2 ・O - 2 Ascorbic Acid Catalase Vitamin E (tocopherol) INHIBITS PEROXIDATION 1000 x Vitamin E** *N.Shimizu et al.: Carotenoids as singlet oxygen quenchers in marine organisms, Fisheries Science, 62, 134-137 (1996). **Miki, W. Pure & Appl. Chem. 63(1);141-46. (ROS: Reactive Oxygen Species) NOV2004 Natural Products Expo Asia 2005 Hong Kong ASTAXANTH I N - I S TH E PU R E ANTI O X I DANT β-Carotene Anti- and Pro-oxidants Lycopene Zeaxanthin Pure Anti-oxidant Astaxanthin 0 1 2 3 4 Normalized relative oxidation rates H.D.Martin, et al. : Chemistry of carotenoid oxidation and free radical reactions, Pure Appl. Chem., 71(12), 2253-2262 (1999). NOV2004 Natural Products Expo Asia 2005 Hong Kong THE ASTAXANTHIN SHIELD Lignell A., & Wood V., Astaxanthin: Radical Cellular Defense. May 2004 Innovations in Food Technology. NOV2004 Natural Products Expo Asia 2005 Hong Kong ASTAXANTH I N D I STR I B UTI O N I N RATS AFTE R 3 WEEKS ON SUPPLEMENTED DIET ( 1 0 0 m g A x / k g f e e d ). 80 70 ASTAXANTHIN SHIELD µg astaxanthin/kg 60 50 40 30 20 10 0 Blood Brain Heart Kidney Liver Lung Muscle Skin Organ US Pat 6,245,818 Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases. NOV2004 Natural Products Expo Asia 2005 Hong Kong PR O PE RTI E S O F ASTAXANTH I N Antioxidant Potency Powerful singlet oxygen quenching and free radical scavenging activity. Protects against lipoperoxidation. Solubility Spans the membrane bi-lipid layer – comprehensive protection and strengthens rigidity Protection Forms a protective shield and defends against continuous free radical attack at the cellular level. Safety Defined as a pure antioxidant unlike other well known antioxidants that can become pro-oxidants. NOV2004 Natural Products Expo Asia 2005 Hong Kong CATERGORIZED CATE R G O RY LITERATURE PU B LI CATI O N S General Nutrition Antioxidant potency, Synergies. Stomach & Gut Health* Helicobacter, dyspepsia Eye Health** Visual Fatigue, Diabetic Cataract Sports Nutrition* Muscle Endurance and damage, Visual Acuity, anti-inflammatory. Fertility, muscle endurance, antiinflammatory UVR damage, photoprotectant, anti-inflammatory. Vetinary Health* Cosmecuticals *Patent Protected **Patent Applied NOV2004 Natural Products Expo Asia 2005 Hong Kong • Sports nutrition & supplement – Major market potential. Continues positive growth. • Strenuous physical activity generates free radicals – up to 12 times more than at rest • Activation of the inflammation response – Important factor for post strenuous exercise & recovery • Feel oxidative damage – Muscle pain, tiredness, need for recovery NOV2004 Natural Products Expo Asia 2005 Hong Kong Dietary supplementation with astaxanthin improves muscle endurance. A randomised double blind placebo controlled study on healthy male subjects. Protocol 40 young healthy male students, age 17 - 19, were included. Standardized exercise tests were carried out at baseline and after three and six months of supplementation with 4 mg astaxanthin per day or placebo. Inclusion Randomisation 4 mg astaxanthin Placebo 3 months Parameters measured: - Fitness - Strength / endurance - Strength / explosivity 3 months (In Press) Investigator Curt L. Malmsten, PhD, MD, Räddningshälsan AB, Sweden. NOV2004 Natural Products Expo Asia 2005 Hong Kong RESULTS: CHANGES IN STRENGTH/ENDURANCE 80 No difference in fittness. No difference in muscle explosivity. 75 Placebo 70 No. of knee bendings/person Significant increase of muscle endurance. Astaxanthin 65 60 55 50 45 40 35 30 1 Baseline Baseline 2 3 3 months 6 months p < 0.05 NOV2004 Natural Products Expo Asia 2005 Hong Kong CONCLUSIONS Astaxanthin may be effective for: Endurance Levels (4 mg daily dose) Maintains Antioxidant Protection Levels Reduces Recovery Time to Training 2002 Sawaki K., et al., reported a 28.5% (P<0.05%) reduction in lactic acid build up after 1200m supplemented subjects. On-going US and Swedish clinical trials. Results Due 1st QTR 2005. Muscle endurance US Pat 6,245,818 NOV2004 Natural Products Expo Asia 2005 Hong Kong Astaxanthin Limits Exercise-Induced Skeletal and Cardiac Muscle Damage in Mice Protocol 1wk 3wk Acclimatization 24hr Training Program ・Control (N=8) ・Exercise Control (N=8) ・Exercise Supplemented (N=8) Exercise Euthanized Damage Markers Muscle cell staining – Cell membrane damage Creatine kinase (CK) – Damaged muscle cells 8-hydroxy-2’-deoxyguanosine (OHdG) – DNA damage Myeloperoxidase (MPO) - Inflammation Aoi, W. et al. 2003, Antioxidants & Redox Signalling, 5:(1) 139-144. NOV2004 Natural Products Expo Asia 2005 Hong Kong MUSCLE CELL MEMBRANE Heart CONTROL EXERCISE CONTROL EXERCISE + AX EXERCISE CONTROL EXERCISE + AX Gastrocnemius CONTROL NOV2004 Natural Products Expo Asia 2005 Hong Kong R E S U LT S Production of 8-OHdG (DNA Damage) Inflammation in Gastrocnemius and Heart 1.50 3.00 p< 0.05 *P<0.05 MPO Activity (mU/mg protein) 1.00 5 8-OHdG/10 xdG p< 0.05 0.50 *P<0.05 *P<0.05 *P<0.05 2.50 2.00 1.50 1.00 0.50 0.00 0.00 Control Exercised Gastrocnemius Ax+ Exercised Control Exercised Ax+Exercised Control Exercised Ax+Exercised Control Gastrocnemius Heart Exercised Ax+Exercised Heart Creatine Kinase in Plasma Overall Reduction of DNA damage 3500 p<0.05 p<0.05 3000 Reduction of Inflammatory Response New Research to Mechanism using Gene Chip Analysis - 2005 2000 U/L Reduction of Muscle Cell Damage 2500 1500 1000 500 0 Control Exercised Ax+Exercised NOV2004 Natural Products Expo Asia 2005 Hong Kong I N F LAM MAT O R Y R E S P O N S E – I N A C T I V A T I O N OF N F – K B Lignell A., & Wood V., Astaxanthin: Radical Cellular Defense. May 2004 Innovations in Food Technology. NOV2004 Natural Products Expo Asia 2005 Hong Kong NOV2004 Natural Products Expo Asia 2005 Hong Kong EYE H EALTH - FAT I G U E Visual Display Terminals (VDT) at work and leisure. Increased Risk of developing glaucoma for heavy computer use combined with short sightedness*. Eye Disorders – Blurring, Occular & Visual Asthenopia, Headache Visual Acuity, Accommodation, Critical flicker fusion, Depth Perception, Pattern Evoked Potential Deteriorates on Daily Basis & Fatigue Accumulates Age Related Macular Degeneration** No Data on Astaxanthin on VDT Induced Visual Fatigue *Source: BBC News 16 Nov 2004 Japanese research 10,000 Japanese workers: Computer link to eye disease. **US Patent 5,527,533, Tso & Lam, “Method of Retarding and Ameliorating Central Nervous System and Eye Damage” NOV2004 Natural Products Expo Asia 2005 Hong Kong C LI N I CAL PARAM ETE R S Visual Acuity (Landolt Ring) 5m & 35 cm Accommodation Amplitude = Ciliary Muscle Function Critical Flicker Fusion (CFF) = Central Nervous System (CNS) Pattern Evoked Potention (PEVP) = Visual Nerve connection the to brain Patient Questionnaire (Subject monitoring devised by Ophthalmologists) *Nagaki Y., et al., 2002 Journal of Traditional Medicines 19(5):170-173. **Koide R., et al., 1994 Effects of Whortleberry extract on ocular function. J. Eye 11:117-121. ***Sawaki K., et al., 2002. Sports Performance Benefits from Taking Natural Astaxanthin Characterized by Visual Acuity and Muscle Fatigue in Humans. J. Clin. Ther. Med. 18(9):73-88. ****Nakamura A., et al., 2004. Changes in Visual Function Following Peroral Astaxanthin. 57th Congress of Clinical Opthalmology of Japan 58(6):1051-1054 (Japanese). NOV2004 Natural Products Expo Asia 2005 Hong Kong EYE FATI G U E C O N C LU S I O N 14 No. of Subje cts w ith Eye Strain Questionnaire revealed a 54% reduction of eye strain symptoms* at 5 mg/day after 4 weeks (N=26) and better accomodation (P<0.01). Agree with Whortleberry** Hypofunction of Ciliary Body 6mg/day*** for 4 weeks (n=18) showed better depth perception and CFF (P<0..05) Accomodation improved at 4 mg (P<0.05) and 12 mg/day (P<0.1) (n=49)**** FOSHU Planned Mid 2005 Agent for improving accommodation blood flow in the eye. 12 10 8 6 4 2 0 Bef ore A f te r G r o u p B ( T r e a te d ) Bef ore A f te r G r o u p C ( Pla c e b o ) V DT S u b je c t s w it h Ey e S t r a in S y m p t o m s b e f o r e a n d a f t e r a s t a x a n t h in s u p p le m e n t a t io n *Nagaki Y., et al., 2002 Journal of Traditional Medicines 19(5):170-173. **Koide R., et al., 1994 Effects of Whortleberry extract on ocular function. J. Eye 11:117-121. ***Sawaki K., et al., 2002. Sports Performance Benefits from Taking Natural Astaxanthin Characterized by Visual Acuity and Muscle Fatigue in Humans. J. Clin. Ther. Med. 18(9):73-88. ****Nakamura A., et al., 2004. Changes in Visual Function Following Peroral Astaxanthin. 58(6):1051-1054 (Japanese). NOV2004 Natural Products Expo Asia 2005 Hong Kong Wrinkles where do you have them? Eyes>Forehead>Mouth UNAVOIDABLE. It’s all part of the aging process. Causes of aging can be partially counteracted. By improving nutrition and minimizing phototic injury. NOV2004 Natural Products Expo Asia 2005 Hong Kong Astaxanthin Early studies in mice models revealed significant long terms protection against premature wrinkle formation caused by UVA and UVB exposure* Topical application lowers the UVB induced inflammatory process that may lead to hyperpigmentation** BEAUTY FROM WITHIN – The Next Hot Market Segment L’Oreal & Nestle – “Innévo” 2002 Targeting women >40 y.o.*** *Arakane K., 2002. Superior protection via astaxanthin. Carotenoid Science, Vol 5. **Yamashita E., 1995. Suppression of Post UVB hyperpigmentation by Topical astaxanthin from krill. Fragrance Journal 14:180-185. ***Times, March 2004 (US) L’Oreal innovations - Beauty foods. NOV2004 Natural Products Expo Asia 2005 Hong Kong Cosmetic benefit of a Dietary Supplement Containing Astaxanthin & Tocotrienol on Human Skin A Randomized Double Blind Placebo Controlled Study Supplemented group - Astaxanthin 2mg from Haematococcus pluvialis - Tocotrienol 40mg from palm fruit - Canola oil Subjects - Healthy female with dry skin conditions - n=8 (supplemented group) + 8 (placebo) - Mean age: 40 years old Methods - 1 capsule per day in the evening for 4 weeks - Parameters measured at start, 2 and 4 weeks Parameters - Standardized questionnaire - Dermatologist inspection/palpation - Skin moisture & sebum content - Magnified skin surface inspection Yamashita, E. 2002, FOOD Style 21, 6:(6) 112-117. NOV2004 Natural Products Expo Asia 2005 Hong Kong NOV2004 Treated Placebo 3.0 p<0.05 2.0 1.0 0.0 -1.0 Total Sag 4 Weeks Pouch Wrinkle Fine wrinkle Dullness Spots/Freckles Redness Acne/Pimples Complexion Oiliness Elasticity Moisture Smoothness Changes of skin condition (-worse/+better) Total Sag 2 Weeks Pouch Wrinkle Fine wrinkle Dullness Spots/Freckles Redness Acne/Pimples Complexion Oiliness Elasticity Moisture Smoothness Changes of skin condition (-worse/+better) RESULTS 1 Natural Products Expo Asia 2005 Hong Kong • Skin condition by individual assessment Treated Placebo 3.0 p<0.05 2.0 1.0 0.0 -1.0 NOV2004 2 Week 2 Traeted Placebo 3 p<0.1 p<0.1 1 0 -1 -2 -3 3 2 Skin color Spots/Freckles Dullness Dark rings around eyes Oiliness Complexion Acne/Pimples Redness Fine wrinkle Wrinkle Skin texture Pouch Sag Smoothness Moisture Pulpfree Elasticity Tough Changes of skin condition (-worse/+better) Skin color Spots/Freckles Dullness Dark rings around eyes Oiliness Complexion Acne/Pimples Redness Fine wrinkle Wrinkle Skin texture Pouch Sag Smoothness Moisture Pulpfree Elasticity Tough Changes of skin condition (-worse/+better) RESULTS 2 Natural Products Expo Asia 2005 Hong Kong • Dermatologist inspection/palpation Week 4 Treated Placebo p<0.05 p<0.01 p<0.1 1 0 -1 -2 -3 NOV2004 RESULTS 3 Natural Products Expo Asia 2005 Hong Kong • Skin moisture content Cheek Placebo 50 15 40 10 30 20 10 0 -10 2 Weeks 4 Weeks Variation (microS) Variation (microS) Eye Region Treated Treated Placebo 5 0 -5 2 Weeks 4 Weeks -10 -15 -20 -20 p<0.05 NOV2004 RESULTS 4 Natural Products Expo Asia 2005 Hong Kong • Skin sebum content Cheek 6 6 4 4 2 2 0 0 -2 -4 -6 2 Weeks 4 Weeks Variation Variation Brow Treated Placebo -2 2 Weeks Treated Placebo 4 Weeks -4 -6 -8 -8 -10 -10 -12 -12 NOV2004 RESULTS 5 Natural Products Expo Asia 2005 Hong Kong • Magnified skin surface inspection M4 Start 2 weeks 4 weeks NOV2004 Possible Mechanism of Action - Visual Wrinkle Reduction - Natural Products Expo Asia 2005 Hong Kong 1 1 1 O2 O2 Singlet oxygen induced UVA oxidizes collagen O2 Tocotrienol Astaxanthin Astaxanthin Tocotrienol New Collagen Thank you !! → WRINKLE NOV2004 Natural Products Expo Asia 2005 Hong Kong CONCLUSION Astaxanthin & Tocotrienol supplementation resulted in • Increased moisture levels • Consistent natural oils • Reduction of fine wrinkles and pimples • Improved elasticity • Reduced swelling under the eyes NOV2004 Natural Products Expo Asia 2005 Hong Kong JAPAN E S E R ETAI L PR O D U CTS Astaxanthin + Tocotrienol & SOD 60 soft cap 3,800 JPY/month 37 USD or 287 HKD Astaxanthin & Blueberry Astaxanthin 1mg/day + DHA+ARA Pure Astaxanthin Astaxanthin & Natto Kinase 6,300 JPY/month 61 USD or 477 HKD Astaxanthin 2mg/day+ pomegranate juice 500mL. 6,000 JPY/month, 58 USD or 453 HKD NOV2004 Natural Products Expo Asia 2005 Hong Kong JAPAN E S E R ETAI L PR O D U CTS CO SM ECEUTICALS & BEAUTY SUPPLEM ENTS NatuReal Corp. Astaxanthin, Tocotrienol & Collagen Supplement 7,000 JPY/month Cream 9000 JPY Essence 10,000 JPY 68-97 USD or 529-755 HKD Shiseido: Pure White Astaxanthin 0.5 mg/day plus multivitamins. Drink 250 JPY 250 mL/day, 2.40 USD or 18.9 HKD Tablet 4000 JPY/ month, 39 USD or 302 HKD NOV2004 Natural Products Expo Asia 2005 Hong Kong R E G U LAT O R Y I N F O R MAT I O N US DSHEA granted for 2 mg/day – 4 mg/day. No GRAS status CFTA/INCI Listed Japan Listed under Food Additives & Colouring JP Cosmetic Listed Europe Only biomass approved EU approvals not yet harmonised Requires EU Novel Foods Approval Country Specific China/Hong Kong Rquires “Bao Jian Shipin” or Health Enchaning Foods approval No information available NOV2004 Natural Products Expo Asia 2005 Hong Kong C O NTAC T I NTE R NATI O NAL MAR K ETI N G S E CTI O N 3rd F L R H A L I F A X O N A R I M O N B L D. 3 – 2 4 –1 0 N I S H I S H I N B A S H I M I NATO – K U TO KYO 1 0 5 –0 0 0 3 JAPAN (T) +81–3–3437–2353 (F) +81–3–3437–2347 www.fujichemical.co.jp/english Email: info@fujichemical.co.jp Thank you for your kind attention! For more information vist Booth E17 NOV2004